- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
+0.15| Last Update: 05/17/13 - 4:00 PM EDT |
| Volume: 357,042 |
| YTD Performance: -1.65% |
| Open: $11.16 |
| Previous Close: $11.12 |
| 52 Week Range: $8.81 - $15.95 |
| Oustanding Shares: 31,464,919 |
| Market Cap: 349,889,899 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.10 | $0.14 | $0.51 | $0.55 |
| Number of Analysts | 7 | 7 | 7 | 7 |
| High Estimate | $0.15 | $0.17 | $0.60 | $0.65 |
| Low Estimate | $0.03 | $0.12 | $0.46 | $0.44 |
| Prior Year | $0.27 | $0.33 | $1.08 | $0.51 |
| Growth Rate (Year over Year) | -61.90% | -58.44% | -52.51% | 7.24% |
Companies that provide end-of-life services have demographics on their side.
Amedisys numbers raised at JefferiesShares of AMED now seen reaching $14, Jefferies said. Estimates also raised on improving admissions trends. Hold rating.
Amedisys numbers lowered at JefferiesShares of AMED now seen reaching $15, Jefferies said. Estimates also lowered on reimbursement uncertainty. Hold rating.
These stocks stand to benefit if Americans can accept the fact that rising health care costs aren't magically going away.
Amedisys numbers raised at JefferiesShares of AMED now seen reaching $16.50, Jefferies said. Estimates also raised to reflect benefit of agency rationalization efforts. Hold rating.
Financial pain caused by a flat yield curve will cascade from the insurance industry into health care.